Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis.
Saved in:
| Title: | Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis. |
|---|---|
| Authors: | Geidel, Glenn1,2 (AUTHOR) g.geidel@uke.de, Bänsch, Sabrina1 (AUTHOR), Adam, Laura1 (AUTHOR), Fekade, Nathan1 (AUTHOR), Rünger, Alessandra1,2 (AUTHOR), Zell, Tim1,2 (AUTHOR), Smit, Daniel J.2,3 (AUTHOR), Kött, Julian1,2 (AUTHOR), Heidrich, Isabel1,2,3 (AUTHOR), Weichenthal, Michael4 (AUTHOR), Ugurel, Selma5 (AUTHOR), Leiter, Ulrike6 (AUTHOR), Mohr, Peter7 (AUTHOR), Geusau, Alexandra8 (AUTHOR), Grabbe, Stephan9 (AUTHOR), Heppt, Markus V.10 (AUTHOR), Gutzmer, Ralf11 (AUTHOR), Utikal, Jochen12,13,14 (AUTHOR), Simon, Jan‐Christoph15 (AUTHOR), Haferkamp, Sebastian16 (AUTHOR) |
| Source: | Journal of the European Academy of Dermatology & Venereology. Jan2026, p1. 10p. 4 Illustrations. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!